Clinical Trials Directory

Trials / Completed

CompletedNCT01762397

A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers

A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
37 (estimated)
Sponsor
PharmaKing · Industry
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The Purpose of a randomized, double-blind, placebo-controlled, single-dose, dose-escalation clinical trial is to explore investigate the safety, tolerability, pharmacokinetics, and food effect of PMK-S005 after oral administration in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGPMK-S005

Timeline

Start date
2012-12-01
Primary completion
2013-05-01
First posted
2013-01-07
Last updated
2014-05-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01762397. Inclusion in this directory is not an endorsement.